HeartSciences Brings Diastolic Dysfunction Assessment to Life with New AI Patent

HeartSciences Brings Diastolic Dysfunction Assessment to Life with New AI Patent

MyoVista wavelet ECG from HeartSciences. [Photo: HeartSciences] In a potentially major advancement in cardiac care using ECG testing, Southlake medtech HeartSciences has been granted a patent by the United States Patent and Trademark Office for the “ECG Quantification of Echocardiographic Measurements of Diastolic Function of the Heart” using of AI technology. Heart Test Laboratories, doing …

HeartSciences Brings Diastolic Dysfunction Assessment to Life with New AI Patent Read More »